About Menotropin
Class: | Gonadotropin (FSH and LH activity)
Use: | Indicated for the treatment of infertility in women, particularly in assisted reproductive technology (ART) protocols, and for the stimulation of spermatogenesis in men with hypogonadotropic hypogonadism.
Adult dose: | Women: 150 IU administered subcutaneously or intramuscularly, typically starting on day 2 or 3 of the menstrual cycle, adjusted based on ovarian response; Men: 150 IU administered subcutaneously or intramuscularly, 2 to 3 time
Drug Class
Gonadotropin (FSH and LH activity)
Uses & Indications
Indicated for the treatment of infertility in women, particularly in assisted reproductive technology (ART) protocols, and for the stimulation of spermatogenesis in men with hypogonadotropic hypogonadism.
Storage Requirements
Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light and keep in the original packaging until use.
Manufacturer & Packaging
Manufacturer: IBSA Institut Biochimique S.A., SWITZERLAND
Package Size
1's [1 Vial of Lyophilized Powder + 1 Ampoule of Solvent]
Price & Supplier
Price in UAE: AED 152.00
Dosage Information
Adult Dose
Women: 150 IU administered subcutaneously or intramuscularly, typically starting on day 2 or 3 of the menstrual cycle, adjusted based on ovarian response; Men: 150 IU administered subcutaneously or intramuscularly, 2 to 3 times per week.
Pediatric Dose
Not applicable; safety and efficacy have not been established in pediatric populations.
Side Effects
Common side effects include headache, abdominal pain, injection site reactions, ovarian hyperstimulation syndrome (OHSS), and mood swings.
Contraindications & Precautions
Contraindicated in patients with hypersensitivity to menotropins or any component of the formulation, uncontrolled thyroid or adrenal dysfunction, ovarian cysts or enlargement, and in the presence of tumors of the pituitary gland or hypothalamus.
Important Warnings
Monitor for signs of OHSS, especially in women undergoing ovarian stimulation. Use with caution in patients with a history of thromboembolic disorders. Regular monitoring of ovarian response is recommended during treatment.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.